Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. (NCI04) [ ]
Term info
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
- Recombinant Fowlpox-CEA-TRICOM Vaccine
- fowlpox-CEA-B7.1/ICAM-1/LFA-3
- rF-CEA(6D)TRICOM
NCIT_C116978, NCIT_C128784, NCIT_C116977
CTRP
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
http://purl.obolibrary.org/obo/NCIT_C25159
Fowlpox-CEA-TRICOM_Vaccine
710068
38216
Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine
Pharmacologic Substance, Virus
C0935790
C2620
Term relations
- Recombinant Fowlpox-TRICOM Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Gene Regulation Process
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation